Study shows GSK's niraparib can slow prostate cancer growth
(Alliance News) - Patients with a certain form of aggressive prostate cancer could benefit from a new combination of drugs which slow cancer growth, according to a new study. Read More
Price | 1,606.50p on 07-10-2025 | at 11:00:49
---|---|
Change | -9.50p -0.59% |
Buy | 1,607.00p |
Sell | 1,606.00p |
Last Trade: | Sell 1.00 at 1,606.00p |
Day's Volume: | 1,062,752 |
Last Close: | 1,616.00p |
Open: | 1,600.00p |
ISIN: | GB00BN7SWP63 |
Day's Range | 1,597.50p - 1,611.00p |
52wk Range: | 1,242.50p - 1,684.50p |
Market Capitalisation: | £64.64b |
VWAP: | 1,603.09982p |
Shares in Issue: | 4.02b |
Glaxosmithkline (GSK) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Sell* | 1 | 1,606.00p | SI Trade |
12:00:48 - 07-Oct-25 |
Unknown* | 0 | 1,606.00p | SI Trade |
12:00:38 - 07-Oct-25 |
Sell* | 580 | 1,606.317p | Ordinary |
12:00:36 - 07-Oct-25 |
Buy* | 1 | 1,607.00p | SI Trade |
12:00:31 - 07-Oct-25 |
Unknown* | 0 | 1,606.50p | SI Trade |
12:00:22 - 07-Oct-25 |
Sell* | 69 | 1,606.50p | Automatic Execution |
12:00:22 - 07-Oct-25 |
Sell* | 747 | 1,606.80p | Ordinary |
12:00:20 - 07-Oct-25 |
Sell* | 1,307 | 1,607.00p | Automatic Execution |
12:00:10 - 07-Oct-25 |
Sell* | 392 | 1,607.00p | Automatic Execution |
12:00:10 - 07-Oct-25 |
Unknown* | 0 | 1,607.50p | SI Trade |
12:00:00 - 07-Oct-25 |
Glaxosmithkline (GSK) Regulatory News |
||
Date | Source | Headline |
---|---|---|
6th Oct 2025 7:00 am | RNS | Transaction in Own Shares |
3rd Oct 2025 7:00 am | RNS | Transaction in Own Shares |
2nd Oct 2025 7:00 am | RNS | Transaction in Own Shares |
1st Oct 2025 3:00 pm | RNS | Total Voting Rights |
1st Oct 2025 7:00 am | RNS | Transaction in Own Shares |
30th Sep 2025 7:00 am | RNS | GSK - third tranche of share buyback programme |
29th Sep 2025 7:00 am | RNS | GSK appoints CEO designate |
22nd Sep 2025 3:30 pm | RNS | Director/PDMR Shareholding |
19th Sep 2025 7:00 am | RNS | Transaction in Own Shares |
18th Sep 2025 7:00 am | RNS | Transaction in Own Shares |